Causal Directed Acyclic Graphs to Mitigate Confounding Bias in Exposure-Response Analyses

Area of Science:

• Pharmacometrics
• Causal Inference
• Oncology Drug Development

Background:

• Exposure-response (E-R) analysis is crucial for drug development and treatment individualization.
• Estimating the causal effect of drug exposure on response can be challenging due to confounding.
• Confounding can obscure the true relationship between drug exposure and patient outcomes.

Purpose of the Study:

• To examine confounding in E-R analyses within oncology using causal inference.
• To demonstrate the utility of causal directed acyclic graphs (DAGs) in understanding confounding challenges.
• To identify potential solutions for mitigating confounding in E-R analyses in oncology.

Main Methods:

• Application of causal inference principles to E-R analysis.
• Utilizing causal directed acyclic graphs (DAGs) to visualize and analyze confounding factors.
• Review and perspective on existing methodologies and challenges in oncology E-R analysis.

Main Results:

• Causal inference provides a framework to identify and address confounding in E-R relationships.
• DAGs visually represent complex causal pathways, aiding in the understanding of confounding.
• The proposed causal approach can lead to more reliable estimation of drug effects.

Conclusions:

• Causal inference and DAGs are powerful tools for navigating confounding in oncology E-R analysis.
• Adopting causal methods can improve the accuracy of drug effect estimation.
• This approach supports more robust drug development and personalized treatment strategies.